BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1)

Related Experiment Video

Updated: Oct 5, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Franzén A1, N E Heldin

  • 1Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University Hospital, SE-751 85 Uppsala, Sweden. Asa.Franzen@genpat.uu.se

Biochemical and Biophysical Research Communications
|July 17, 2001
PubMed

Insights

Bone morphogenetic protein-7 (BMP-7) inhibits anaplastic thyroid carcinoma cell growth by halting cell cycle progression. This BMP-7 effect is density-dependent and involves regulating key cell cycle proteins.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Thyroid carcinoma is a significant health concern.
  • Anaplastic thyroid carcinoma (ATC) is an aggressive subtype with limited treatment options.
  • Understanding the molecular mechanisms regulating ATC cell growth is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the impact of bone morphogenetic protein-7 (BMP-7) on the proliferation of human anaplastic thyroid carcinoma cell lines.
  • To elucidate the underlying molecular mechanisms by which BMP-7 affects thyroid carcinoma cell growth.

Main Methods:

  • Treatment of six human anaplastic thyroid carcinoma cell lines with BMP-7.
  • Assessment of cell proliferation using (3)H-thymidine incorporation and cell counting.
  • Cell cycle analysis via flow cytometry.
  • Evaluation of cyclin-dependent kinase inhibitors (CDKIs), Cdk activity, and retinoblastoma protein (pRb) phosphorylation status.

Main Results:

  • BMP-7 inhibited proliferation in four out of six tested ATC cell lines in a cell density-dependent manner.
  • BMP-7 treatment led to an accumulation of cells in the G1 phase and a reduction in S and G2/M phases.
  • BMP-7 upregulated p21 and p27 CDKIs, decreased Cdk2 and Cdk6 activity, and promoted pRb hypophosphorylation.

Conclusions:

  • BMP-7 exhibits a growth-inhibitory effect on anaplastic thyroid carcinoma cells.
  • The mechanism involves BMP-7-induced inhibition of Cdk activity, leading to a shift in pRb to its hypophosphorylated state and cell cycle arrest.
  • BMP-7 represents a potential therapeutic agent for anaplastic thyroid carcinoma.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.